{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-032430","form_type":"8-K","ticker":"PIII","cik":"0001832511","company_name":"P3 Health Partners Inc.","filed_at":"2023-03-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.929401+00:00","generated_at":"2026-06-18T02:24:37.585368+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"P3 Health Partners reaffirms FY2022 guidance and provides FY2023 outlook; 10-K filing delayed to March 30","bullets":["Reaffirmed FY2022 revenue $1.025B-$1.075B (61%-69% YoY growth) and >100k at-risk MA members.","FY2022 adjusted EBITDA loss reaffirmed at $118M-$128M; FY2023 adjusted EBITDA loss guided at $40M-$60M.","Preliminary 2023 revenue guidance $1.20B-$1.25B; at-risk MA membership 115k-120k.","Expects positive adjusted EBITDA in 2024; 10-K filing delay due to audit timing, not operational issues.","Earnings call scheduled for March 30, 2023 after market close."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-032430","json":"https://secwatch.observer/filing/0001104659-23-032430.json","markdown":"https://secwatch.observer/filing/0001104659-23-032430.md","text":"https://secwatch.observer/filing/0001104659-23-032430.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832511/000110465923032430/0001104659-23-032430-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832511/000110465923032430/tm239604d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T02:24:37.585368+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4ac69cec5e3c06ae0f380eae2d1d14845f2104c5","claim":"P3 Health Partners Inc. updated its fiscal year ended December 31, 2022 guidance (reaffirmed).","evidence_excerpt":"expects to report revenue of between $1.025 billion and $1.075 billion","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832511/000110465923032430/0001104659-23-032430-index.htm","confidence":0.8,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year ended December 31, 2022"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}